Financial results - ANALIMED SRL

Financial Summary - Analimed Srl
Unique identification code: 14406247
Registration number: J01/31/2002
Nace: 8622
Sales - Ron
289.544
Net Profit - Ron
2.764
Employee
9
The most important financial indicators for the company Analimed Srl - Unique Identification Number 14406247: sales in 2023 was 289.544 euro, registering a net profit of 2.764 euro and having an average number of 9 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Analimed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 154.288 192.487 208.958 226.065 246.744 189.817 185.845 223.570 227.105 289.544
Total Income - EUR 154.446 192.844 209.091 226.240 246.960 190.476 186.840 226.719 227.163 289.553
Total Expenses - EUR 148.826 171.830 194.351 219.387 237.913 187.999 182.777 210.064 221.856 284.183
Gross Profit/Loss - EUR 5.620 21.014 14.740 6.852 9.047 2.477 4.063 16.654 5.307 5.370
Net Profit/Loss - EUR 4.697 17.555 12.333 3.433 6.578 606 2.575 14.387 3.308 2.764
Employees 10 11 11 12 12 9 8 8 9 9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 27.9%, from 227.105 euro in the year 2022, to 289.544 euro in 2023. The Net Profit decreased by -534 euro, from 3.308 euro in 2022, to 2.764 in the last year.

Check the financial reports for the company - Analimed Srl

Rating financiar

Financial Rating -
Analimed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Analimed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Analimed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Analimed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Analimed Srl - CUI 14406247

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 96.142 110.273 110.740 109.533 103.119 96.921 92.490 87.817 90.541 86.452
Current Assets 22.367 23.055 26.225 26.890 39.161 25.806 20.860 31.837 28.418 40.092
Inventories 1.490 406 299 1.260 1.547 4.019 2.619 1.117 8.565 10.058
Receivables 16.384 11.600 11.921 20.828 15.623 14.926 4.205 12.736 19.066 24.872
Cash 4.493 11.049 14.005 4.802 21.991 6.861 14.036 17.985 786 5.162
Shareholders Funds 47.059 65.007 76.677 78.812 83.944 82.925 83.928 96.454 97.719 97.963
Social Capital 47 47 47 46 45 44 43 42 43 42
Debts 71.450 68.321 60.288 57.611 58.336 39.803 29.422 23.200 21.239 28.581
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 40.092 euro in 2023 which includes Inventories of 10.058 euro, Receivables of 24.872 euro and cash availability of 5.162 euro.
The company's Equity was valued at 97.963 euro, while total Liabilities amounted to 28.581 euro. Equity increased by 541 euro, from 97.719 euro in 2022, to 97.963 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Analimed Srl

Comments - Analimed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.